Clinical Trial

SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

Name: SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population — clinical trial record (NCT07051603)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated July 4, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to evaluate the safety, tolerability pharmacokinetics and pharmacodynamics of SAL0140 healthy Chinese population.

Trial Details

NCT Number	NCT07051603
Lead Sponsor	Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions	Uncontrolled Hypertension
Enrollment	82 participants
Start Date	2025-06-09
Primary Completion	2026-01 (estimated)
Study Completion	2026-02 (estimated)
Updated on ClinicalTrials.gov	2025-07-04